Theodosopoulos Theodosios K, Marinis Athanasios D, Dafnios Nikolaos A, Vassiliou John G, Samanides Lazaros D, Carvounis Eleni E, Smyrniotis Vassilios E
Second Department of Surgery, Areteion University Hospital, Athens Medical School, University of Athens, 76 Vasilisis Sofias av, 11528, Athens, Greece.
World J Surg Oncol. 2006 Aug 8;4:49. doi: 10.1186/1477-7819-4-49.
Rectal squamous cell carcinoma (SCC) is a rare tumor. The incidence of this malignancy has been reported to be 0.25 to 1 per 1000 colorectal carcinomas. From a review of the English literature 55 cases of SCC of the rectum have been published. In this study we report a rectal metastatic SCC to the liver, discussing the efficacy of aggressive adjuvant and neo-adjuvant therapies on survival and prognosis.
A 39-year-old female patient with a pure SCC of the rectum diagnosed endoscopically is presented. The patient underwent initially neoadjuvant chemo-radiotherapy and then abdominoperineal resection with concomitant bilateral oophorectomy and hysterectomy, followed by adjuvant chemo-radiotherapy. Five months after the initial operation liver metastasis was demonstrated and a liver resection was carried out, followed by adjuvant chemotherapy. Eighteen months after the initial operation the patient is alive.
Although prognosis of rectal SCC is worse than that of adenocarcinoma, an aggressive therapeutic approach with surgery as the primary treatment, followed by combined neo- and adjuvant chemo-radiotherapy, may be necessary in order to improve survival and prognosis.
直肠鳞状细胞癌(SCC)是一种罕见肿瘤。据报道,这种恶性肿瘤在每1000例结直肠癌中的发病率为0.25至1例。通过对英文文献的回顾,已发表了55例直肠SCC病例。在本研究中,我们报告了一例直肠SCC肝转移病例,并讨论积极的辅助和新辅助治疗对生存和预后的疗效。
本文介绍了一名39岁女性患者,经内镜诊断为单纯直肠SCC。该患者最初接受新辅助放化疗,然后行腹会阴联合切除术,同时双侧卵巢切除术和子宫切除术,随后进行辅助放化疗。初次手术后五个月发现肝转移,遂行肝切除术,随后进行辅助化疗。初次手术后18个月,患者仍存活。
尽管直肠SCC的预后比腺癌差,但为了提高生存率和改善预后,可能需要采取以手术为主的积极治疗方法,随后联合新辅助和辅助放化疗。